CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$532.88

Market cap

$6.96B

P/E Ratio

26.78

Dividend/share

$2.4

EPS

$19.9

Enterprise value

$7.22B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 70

Chemed Corporation (Chemed) purchases, operates and divests subsidiaries engaged in diverse business activities. During the year ended December 31, 2012, Chemed operated in two segments: the Vitas segment (Vitas) and ...

Highlights
The EPS has increased by 8% from the previous quarter
CHE's gross profit is up by 4.5% since the previous quarter
The price to earnings (P/E) is 18% higher than the last 4 quarters average of 22.7 but 4.7% lower than the 5-year quarterly average of 28.1
The net income has grown by 6% since the previous quarter but it has declined by 5% year-on-year
The debt has soared by 103% year-on-year and by 24% since the previous quarter
Chemed's quick ratio has plunged by 56% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com
Peers: SXT BCPC RPM

Key stats

What are the main financial stats of CHE

CHE stock price

How has the Chemed stock price performed over time
Intraday
-0.8%
1 week
-3.59%
1 month
8.33%
1 year
20.05%
YTD
24.55%
QTD
14.42%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.6B
Gross profit
$859.31M
Operating income
$349.19M
Net income
$274.99M
Gross margin
33.1%
Net margin
10.6%
The net margin is down by 9% year-on-year but it is up by 3.9% since the previous quarter
The operating margin has decreased by 8% YoY but it has increased by 4.7% QoQ
The net income has grown by 6% since the previous quarter but it has declined by 5% year-on-year
Chemed's operating income has increased by 6% from the previous quarter but it has decreased by 5% YoY

Price vs fundamentals

How does CHE's price correlate with its fundamentals

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
CHE P/E details
P/E
26.78
P/B
8.52
P/S
2.71
EV/EBIT
19.38
EV/EBITDA
16.45
EV/Sales
2.78
The price to earnings (P/E) is 18% higher than the last 4 quarters average of 22.7 but 4.7% lower than the 5-year quarterly average of 28.1
The EPS has increased by 8% from the previous quarter
The P/B is 31% more than the last 4 quarters average of 6.5 and 3.9% more than the 5-year quarterly average of 8.2
Chemed's equity has decreased by 31% YoY and by 2.1% from the previous quarter
CHE's P/S is 18% below its 5-year quarterly average of 3.3 but 18% above its last 4 quarters average of 2.3
The revenue rose by 3.3% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Chemed business performance
The ROE has grown by 20% YoY and by 17% from the previous quarter
The company's return on invested capital fell by 11% YoY
The ROA rose by 8% since the previous quarter and by 3.6% year-on-year
The ROS has decreased by 7% YoY but it has increased by 4.3% from the previous quarter

Dividends

What is CHE's dividend history
Dividend details
DPS
$2.4
Dividend yield
0.45%
Payout ratio
12.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Chemed financials performed over time
Chemed's total assets is 111% higher than its total liabilities
Chemed's quick ratio has plunged by 56% YoY
CHE's current ratio has plunged by 51% YoY but it is up by 7% from the previous quarter
The debt is 65% smaller than the equity
CHE's debt to equity has surged by 192% year-on-year and by 25% since the previous quarter
The debt has soared by 103% year-on-year and by 24% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.